Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential inquiry. [electronic resource]
Producer: 19980513Description: 1191-6 p. digitalISSN:- 0959-8138
- Antiparkinson Agents -- adverse effects
- Bromocriptine -- adverse effects
- Cause of Death
- Persons with Disabilities
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Humans
- Levodopa -- adverse effects
- Male
- Parkinson Disease -- drug therapy
- Proportional Hazards Models
- Selegiline -- adverse effects
- Survival Rate
- Treatment Failure
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.